Literature DB >> 9498072

Cytokine and protease glycosylation as a regulatory mechanism in inflammation and autoimmunity.

P Van den Steen1, P M Rudd, R A Dwek, J Van Damme, G Opdenakker.   

Abstract

Cytokines are locally produced hormones that alert the innate and specific immune systems. Many cytokines induce, enhance and govern the traffic of leukocytes. An important mechanism in cell trafficking and migration through endothelial basement membranes and connective tissues is the cytokine-regulated production of matrix degrading proteases. The latter include the serine proteinases of plasminogen activation and metalloproteinases such as collagenases, stromelysins and gelatinases. Many cytokines and all known matrix proteinases are glycoproteins and thus occur as sets of glycoforms. The relation between structures and functions of these glycoproteins has already been probed extensively at the protein level but not yet at the carbohydrate level. Attached oligosaccharides target the cytokines and proteinases to specific cellular receptors and matrix binding sites. In addition, a number of cytokines possess lectin-like functions and may thus interact with carbohydrates of the host or parasites. These intermolecular interactions influence for instance the compartmentalisation, the cell- and tissue-specific distribution and the pharmacokinetics of cytokines and proteinases. Attempts were done to deduce structure-function rules for the intramolecular effects of carbohydrates on cytokines and matrix proteinases. The relatively voluminous N-linked sugars downmodulate the specific activities of enzymes and cytokines. Because in host stress reactions (infection, inflammation, trauma) N-linked glycosylation is less efficient, glycosylation may constitute an important regulatory mechanism in the cytokine network and in multi-enzyme cascades.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9498072     DOI: 10.1007/978-1-4615-5383-0_13

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

1.  Production of biologically active GM-CSF in sugarcane: a secure biofactory.

Authors:  Ming-Li Wang; Cindy Goldstein; Winston Su; Paul H Moore; Henrik H Albert
Journal:  Transgenic Res       Date:  2005-04       Impact factor: 2.788

2.  Glycosylation of FcgammaRIII in N163 as mechanism of regulating receptor affinity.

Authors:  Bettina Drescher; Torsten Witte; Reinhold E Schmidt
Journal:  Immunology       Date:  2003-11       Impact factor: 7.397

3.  Ileal Immunoglobulin Binding by the Neonatal Fc Receptor: A Previously Unrecognized Mechanism of Protection in the Neonatal Rat Model of Necrotizing Enterocolitis?

Authors:  Jonathan R Swanson; Tamas Jilling; Jing Lu; Jessica B Landseadel; Marek Marcinkiewicz; Phillip V Gordon
Journal:  EJ Neonatol Res       Date:  2011-03-03

4.  Inhibition of the oligosaccharyl transferase in Caenorhabditis elegans that compromises ER proteostasis suppresses p38-dependent protection against pathogenic bacteria.

Authors:  Dae-Eun Jeong; Yujin Lee; Seokjin Ham; Dongyeop Lee; Sujeong Kwon; Hae-Eun H Park; Sun-Young Hwang; Joo-Yeon Yoo; Tae-Young Roh; Seung-Jae V Lee
Journal:  PLoS Genet       Date:  2020-03-04       Impact factor: 5.917

5.  Shrimp Plasma CREG Is a Hemocyte Activation Factor.

Authors:  Zhiqi Huang; Peng Yang; Fan Wang
Journal:  Front Immunol       Date:  2021-08-16       Impact factor: 7.561

6.  Erythropoiesis stimulating agents: approaches to modulate activity.

Authors:  Angus M Sinclair
Journal:  Biologics       Date:  2013-07-03

7.  Insights into non-autoimmune type 1 diabetes with 13 novel loci in low polygenic risk score patients.

Authors:  Jingchun Qu; Hui-Qi Qu; Jonathan P Bradfield; Joseph T Glessner; Xiao Chang; Lifeng Tian; Michael March; John J Connolly; Jeffrey D Roizen; Patrick M A Sleiman; Hakon Hakonarson
Journal:  Sci Rep       Date:  2021-08-06       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.